Expression of the p53 and maspin protein in primary prostate cancer: Correlation with clinical features
Open Access
- 24 July 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 95 (5) , 337-342
- https://doi.org/10.1002/1097-0215(20010920)95:5<337::aid-ijc1059>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Maspin is an angiogenesis inhibitorNature Medicine, 2000
- The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomyEuropean Journal Of Cancer, 1998
- Cytoplasmic Antiproteinase 2 (PI8) and Bomapin (PI10) Map to the Serpin Cluster at 18q21.3Genomics, 1997
- Expression of maspin in prostate cells is regulated by a positive Ets element and a negative hormonal responsive element site recognized by androgen receptorProceedings of the National Academy of Sciences, 1997
- Rat and human maspins: structures, metastatic suppressor activity and mutation in prostate cancer cellsCancer Letters, 1997
- The myoepithelial defense: a host defense against cancerMedical Hypotheses, 1997
- Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.Proceedings of the National Academy of Sciences, 1996
- Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin geneAnnals of Oncology, 1996
- Maspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial CellsScience, 1994